Should You Buy ICON Public Limited Company Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, ICON Public Limited Company (ICLR) registers a weak Quality of Company score of 2.8/10. At the current price of $172.45, our 13-model framework evaluates whether the stock's discount is sufficient to compensate for high fundamental risks.
The short answer: 1 of 1 CirclFi valuation models project upside for ICON Public Limited Company (ICLR) at $172.45 — the model consensus leans bullish, with a Quality Score of 2.8/10 and Value-Trap risk of 0/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for ICON Public Limited Company (ICLR) in 2026?
What Is the Bull Case vs the Bear Case for ICON Public Limited Company (ICLR)?
| Bull case — $387.90 target (+124.9%) | Bear case |
|---|---|
| According to the CirclFi Deep Alpha Valuation Engine, the stock shows multi-model upside with a median implied return of +124.9% across 1 bullish models from the current price of $172.45. | No active model flags significant downside for ICLR. The low Value Trap score paints a constructive picture. |
| According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $387.90 (+124.9%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | |
| Industry tailwind: regulatory pathway clarity could provide meaningful support for ICON Public Limited Company's revenue and margin trajectory in the Diagnostics & Research space. |
How Does ICLR Compare to Its Diagnostics & Research Peers?
Valuation data pages: QGEN · MDXH · FUNI · IDXX · NDRA · MEDP · DGX · CRL · IMDX
Which Other Stocks Score Like ICLR on Quality?
Closest companies to ICLR’s Quality of Company score of 2.8/10, across all industries.
- TWG — Top Wealth Group Holding Limited (QOC 2.8) · analysis
- NVS — Novartis AG (QOC 2.8) · analysis
- BTG — B2Gold Corp. (QOC 2.8) · analysis
- RYOJ — rYojbaba Co., Ltd. (QOC 2.8) · analysis
- YALA — Yalla Group Limited (QOC 2.8) · analysis
- ACCL — Acco Group Holdings Limited (QOC 2.8) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
So Is ICON Public Limited Company (ICLR) Worth Buying in 2026?
The convergence of 2.8/10 quality, multi-model undervaluation (1/1 bullish, +124.9% median upside), and a median fair value of $387.90 vs. $172.45 current price makes ICON Public Limited Company one of the more compelling opportunities in our coverage. As always, our models provide a quantitative starting point — not a substitute for individual due diligence.
These are quantitative model outputs, not investment recommendations. ICON Public Limited Company's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About ICLR Stock?
Should I buy ICLR stock right now?
Based on CirclFi's multi-model analysis, 1 of 1 models see upside for ICLR at $172.45. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 2.8/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in ICON Public Limited Company?
Key risks include: a below-average Quality Score of 2.8/10, indicating fundamental weakness; limited model coverage (1/13 active), reducing analytical confidence; general market and sector-specific risks affecting Diagnostics & Research companies. Always diversify and consult a financial advisor.
How does ICLR compare to its competitors?
Among Diagnostics & Research peers, ICLR holds a Quality Score of 2.8/10. Comparable companies include QGEN (QOC 3.2), MDXH (QOC 2.3), FUNI (QOC 3.9). The relative ranking helps investors identify whether ICLR offers better fundamental quality than alternatives in the same sector.
Is ICLR a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. ICLR's Quality Score of 2.8/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.
What price should I buy ICLR at?
CirclFi does not provide target buy prices or price alerts. However, our 1 active models produce fair value estimates ranging from $387.90 to $387.90. At $172.45, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for ICLR.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad